Abstract
A potential link between mortality, d-dimer values, and a prothrombotic syndrome has been reported in patients with coronavirus disease 2019 (COVID-19) infection. The National Institute for Public Health of the Netherlands asked a group of radiology and vascular medicine experts to provide guidance for the imaging work-up and treatment of these important complications. This report summarizes evidence for thromboembolic disease, potential diagnostic and preventive actions, and recommendations for prophylaxis and treatment of patients with COVID-19 infection.
© RSNA, 2020.
MeSH terms
-
Adult
-
Betacoronavirus / isolation & purification
-
COVID-19
-
Coronavirus Infections / blood*
-
Coronavirus Infections / mortality
-
Coronavirus Infections / pathology
-
Disseminated Intravascular Coagulation / diagnosis
-
Disseminated Intravascular Coagulation / prevention & control
-
Disseminated Intravascular Coagulation / therapy
-
Disseminated Intravascular Coagulation / virology
-
Female
-
Fibrin Fibrinogen Degradation Products / analysis
-
Humans
-
Lung / pathology
-
Male
-
Middle Aged
-
Netherlands / epidemiology
-
Pandemics
-
Pneumonia, Viral / blood*
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / pathology
-
Practice Guidelines as Topic
-
Public Health
-
Retrospective Studies
-
SARS-CoV-2
-
Thromboembolism / diagnosis
-
Thromboembolism / prevention & control
-
Thromboembolism / therapy*
-
Thromboembolism / virology*
-
Tomography, X-Ray Computed
Substances
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D